When TdB Labs was founded, the company was first mostly a consultancy enterprise and was therefore called TdB Consultancy. Products for research and development in pharmaceuticals, diagnostics and biotech were introduced as the company grew. About 20 years ago, TdB Labs was involved in developing a dextran sulfate sodium (DSS) for inducing colitis, which has proved an invaluable tool for studying the causes and treatment of inflammation in the gut.
In 2009, TdB Labs moved to new premises in Uppsala Business Park and begun a period of expansion. At that time, Tony’s’ daughter Charlotte de Belder Tesséus, took over the role as CEO. Tony stays within the company as a Scientific Consultant and member of the Board. In 2019, the company changed name from TdB Consultancy to TdB Labs.
